Adage Capital Partners
AGRX

Adage Capital Partners’s Agile Therapeutics AGRX Stock Holding History

Adage Capital Partners’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-850
Closed -$9.69M – 755
2016
Q4 		$9.69M Hold
850
– – 0.03% 534
2016
Q3 		$11.9M Hold
850
– – 0.03% 487
2016
Q2 		$12.9M Hold
850
– – 0.04% 464
2016
Q1 		$10.6M Buy
850
+150
+21% +$1.94M 0.03% 505
2015
Q4 		$13.7M Buy
700
+2
+0.3% +$31.6K 0.04% 465
2015
Q3 		$9.41M Hold
698
– – 0.03% 544
2015
Q2 		$12M Hold
698
– – 0.03% 520
2015
Q1 		$12.9M Buy
698
+98
+16% +$1.72M 0.03% 513
2014
Q4 		$7.37M Hold
600
– – 0.02% 579
2014
Q3 		$8.76M Hold
600
– – 0.02% 552
2014
Q2 		$10.5M Buy
+600
New +$8.68M 0.03% 520

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return